228 related articles for article (PubMed ID: 16676347)
1. Cancer progression by non-clonal chromosome aberrations.
Heng HH; Bremer SW; Stevens J; Ye KJ; Miller F; Liu G; Ye CJ
J Cell Biochem; 2006 Aug; 98(6):1424-35. PubMed ID: 16676347
[TBL] [Abstract][Full Text] [Related]
2. Stochastic cancer progression driven by non-clonal chromosome aberrations.
Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
[TBL] [Abstract][Full Text] [Related]
3. The dynamics of cancer chromosomes and genomes.
Ye CJ; Liu G; Bremer SW; Heng HH
Cytogenet Genome Res; 2007; 118(2-4):237-46. PubMed ID: 18000376
[TBL] [Abstract][Full Text] [Related]
4. Clonal and non-clonal chromosome aberrations and genome variation and aberration.
Heng HH; Liu G; Bremer S; Ye KJ; Stevens J; Ye CJ
Genome; 2006 Mar; 49(3):195-204. PubMed ID: 16604101
[TBL] [Abstract][Full Text] [Related]
5. Cancer genome sequencing: the challenges ahead.
Heng HH
Bioessays; 2007 Aug; 29(8):783-94. PubMed ID: 17621658
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
[TBL] [Abstract][Full Text] [Related]
7. Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?
Heng HH; Regan SM; Liu G; Ye CJ
Mol Cytogenet; 2016; 9():15. PubMed ID: 26877768
[TBL] [Abstract][Full Text] [Related]
8. The evolutionary mechanism of cancer.
Heng HH; Stevens JB; Bremer SW; Ye KJ; Liu G; Ye CJ
J Cell Biochem; 2010 Apr; 109(6):1072-84. PubMed ID: 20213744
[TBL] [Abstract][Full Text] [Related]
9. The Importance of Monitoring Non-clonal Chromosome Aberrations (NCCAs) in Cancer Research.
Heng E; Thanedar S; Heng HH
Methods Mol Biol; 2024; 2825():79-111. PubMed ID: 38913304
[TBL] [Abstract][Full Text] [Related]
10. Primary vs. secondary neoplasia-associated chromosomal abnormalities--balanced rearrangements vs. genomic imbalances?
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1996 Jul; 16(3):155-63. PubMed ID: 8814447
[TBL] [Abstract][Full Text] [Related]
11. Cancer chromosomes in crisis.
DePinho RA; Polyak K
Nat Genet; 2004 Sep; 36(9):932-4. PubMed ID: 15340427
[TBL] [Abstract][Full Text] [Related]
12. Genomic mechanisms and measurement of structural and numerical instability in cancer cells.
Bayani J; Selvarajah S; Maire G; Vukovic B; Al-Romaih K; Zielenska M; Squire JA
Semin Cancer Biol; 2007 Feb; 17(1):5-18. PubMed ID: 17126026
[TBL] [Abstract][Full Text] [Related]
13. Power law distribution of chromosome aberrations in cancer.
Frigyesi A; Gisselsson D; Mitelman F; Höglund M
Cancer Res; 2003 Nov; 63(21):7094-7. PubMed ID: 14612501
[TBL] [Abstract][Full Text] [Related]
14. The evolutionary origin of genetic instability in cancer development.
Breivik J
Semin Cancer Biol; 2005 Feb; 15(1):51-60. PubMed ID: 15613288
[TBL] [Abstract][Full Text] [Related]
15. Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.
Ye CJ; Stevens JB; Liu G; Bremer SW; Jaiswal AS; Ye KJ; Lin MF; Lawrenson L; Lancaster WD; Kurkinen M; Liao JD; Gairola CG; Shekhar MP; Narayan S; Miller FR; Heng HH
J Cell Physiol; 2009 May; 219(2):288-300. PubMed ID: 19115235
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary mechanisms and diversity in cancer.
Heng HH; Stevens JB; Bremer SW; Liu G; Abdallah BY; Ye CJ
Adv Cancer Res; 2011; 112():217-53. PubMed ID: 21925306
[TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in solid tumors have a stochastic nature.
Castro MA; Onsten TG; Moreira JC; de Almeida RM
Mutat Res; 2006 Aug; 600(1-2):150-64. PubMed ID: 16814328
[TBL] [Abstract][Full Text] [Related]
18. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
Stindl R
Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
[TBL] [Abstract][Full Text] [Related]
19. Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia.
Braude I; Vukovic B; Prasad M; Marrano P; Turley S; Barber D; Zielenska M; Squire JA
BMC Genomics; 2006 Jun; 7():138. PubMed ID: 16756668
[TBL] [Abstract][Full Text] [Related]
20. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
Melchor L; Benítez J
Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
